T1	AdverseReaction 71 90	supine hypertension
T2	AdverseReaction 108 127	cardiovascular risk
T3	AdverseReaction 131 150	supine hypertension
T4	AdverseReaction 187 199	Hyperpyrexia
T5	AdverseReaction 204 213	confusion
T6	AdverseReaction 233 243;279 301	exacerbate ischemic heart disease
T7	AdverseReaction 233 243;303 314	exacerbate arrhythmias
T8	AdverseReaction 233 243;320 344	exacerbate congestive heart failure
T9	Factor 229 232	May
T10	AdverseReaction 471 490	supine hypertension
T11	AdverseReaction 966 996	neuroleptic malignant syndrome
T12	AdverseReaction 998 1001	NMS
T13	AdverseReaction 1275 1278	NMS
T14	Severity 1298 1314	life-threatening
T15	AdverseReaction 1341 1346	fever
T16	AdverseReaction 1350 1362	hyperthermia
T17	AdverseReaction 1364 1379	muscle rigidity
T18	AdverseReaction 1381 1402	involuntary movements
T19	AdverseReaction 1404 1425	altered consciousness
T20	AdverseReaction 1431 1451	mental status change
T21	Factor 1647 1650	may
T22	AdverseReaction 1651 1661;1671 1693	exacerbate ischemic heart disease
T23	AdverseReaction 1651 1661;1695 1706	exacerbate arrhythmias
T24	AdverseReaction 1651 1661;1712 1736	exacerbate congestive heart failure
T25	AdverseReaction 1967 1990	allergic-type reactions
T26	Factor 1957 1960	may
T27	AdverseReaction 2002 2018	bronchial asthma
T28	Factor 61 64	can
T29	Factor 95 98	may
T30	AdverseReaction 360 378	Allergic reactions
T31	Factor 447 450	may
E1	AdverseReaction:T1 Hypothetical:E28
E2	AdverseReaction:T2 Hypothetical:E29
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6 Hypothetical:E9
E7	AdverseReaction:T7 Hypothetical:E9
E8	AdverseReaction:T8 Hypothetical:E9
E9	Factor:T9
E10	AdverseReaction:T10 Hypothetical:E31
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13 Effect:E14
E14	Severity:T14
E15	AdverseReaction:T15
E16	AdverseReaction:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	Factor:T21
E22	AdverseReaction:T22 Hypothetical:E21
E23	AdverseReaction:T23 Hypothetical:E21
E24	AdverseReaction:T24 Hypothetical:E21
E25	AdverseReaction:T25 Hypothetical:E26
E26	Factor:T26
E27	AdverseReaction:T27 Hypothetical:E26
E28	Factor:T28
E29	Factor:T29
E30	AdverseReaction:T30
E31	Factor:T31
A1	flag E1 underspecified
A2	CUI E1 C0020538
A3	UMLS-Preferred-Name E1 Hypertensive disease
A4	MEDDRA-PT E1 Hypertension
A5	MEDDRA-PT-ID E1 10020772
A6	CUI E2 C0850624
A7	UMLS-Preferred-Name E2 cardiovascular risk factor
A8	MEDDRA-PT E2 Cardiovascular symptom
A9	MEDDRA-PT-ID E2 10075534
A10	flag E3 underspecified
A11	CUI E3 C0020538
A12	UMLS-Preferred-Name E3 Hypertensive disease
A13	MEDDRA-PT E3 Hypertension
A14	MEDDRA-PT-ID E3 10020772
A15	CUI E4 C0392676
A16	UMLS-Preferred-Name E4 Hyperpyrexia
A17	MEDDRA-PT E4 Hyperpyrexia
A18	MEDDRA-PT-ID E4 10020741
A19	CUI E5 C0009676
A20	UMLS-Preferred-Name E5 Confusion
A21	MEDDRA-PT E5 Confusional state
A22	MEDDRA-PT-ID E5 10010305
A23	LLT E5 Confusion
A24	LLT-ID E5 10010300
A25	CUI E6 C0151744
A26	UMLS-Preferred-Name E6 Myocardial Ischemia
A27	MEDDRA-PT E6 Myocardial ischaemia
A28	MEDDRA-PT-ID E6 10028600
A29	LLT E6 Ischaemic heart disease
A30	LLT-ID E6 10023024
A31	CUI E7 C0003811
A32	UMLS-Preferred-Name E7 Cardiac Arrhythmia
A33	MEDDRA-PT E7 Arrhythmia
A34	MEDDRA-PT-ID E7 10003119
A35	CUI E8 C3532952
A36	UMLS-Preferred-Name E8 Exacerbation of congestive heart failure
A37	MEDDRA-PT E8 Cardiac failure congestive
A38	MEDDRA-PT-ID E8 10007559
A39	LLT E8 Congestive cardiac failure aggravated
A40	LLT-ID E8 10048565
A41	flag E10 underspecified
A42	CUI E10 C0020538
A43	UMLS-Preferred-Name E10 Hypertensive disease
A44	MEDDRA-PT E10 Hypertension
A45	MEDDRA-PT-ID E10 10020772
A46	CUI E11 C0027849
A47	UMLS-Preferred-Name E11 Neuroleptic Malignant Syndrome
A48	MEDDRA-PT E11 Neuroleptic malignant syndrome
A49	MEDDRA-PT-ID E11 10029282
A50	CUI E12 C0027849
A51	UMLS-Preferred-Name E12 Neuroleptic Malignant Syndrome
A52	MEDDRA-PT E12 Neuroleptic malignant syndrome
A53	MEDDRA-PT-ID E12 10029282
A54	LLT E12 NMS
A55	LLT-ID E12 10029435
A56	CUI E13 C0027849
A57	UMLS-Preferred-Name E13 Neuroleptic Malignant Syndrome
A58	MEDDRA-PT E13 Neuroleptic malignant syndrome
A59	MEDDRA-PT-ID E13 10029282
A60	LLT E13 NMS
A61	LLT-ID E13 10029435
A62	CUI E15 C0015967
A63	UMLS-Preferred-Name E15 Fever
A64	MEDDRA-PT E15 Pyrexia
A65	MEDDRA-PT-ID E15 10037660
A66	LLT E15 Fever
A67	LLT-ID E15 10016558
A68	CUI E16 C0015967
A69	UMLS-Preferred-Name E16 Fever
A70	MEDDRA-PT E16 Hyperthermia
A71	MEDDRA-PT-ID E16 10020843
A72	CUI E17 C0026837
A73	UMLS-Preferred-Name E17 Muscle Rigidity
A74	MEDDRA-PT E17 Muscle rigidity
A75	MEDDRA-PT-ID E17 10028330
A76	CUI E18 C0427086
A77	UMLS-Preferred-Name E18 Involuntary Movements
A78	MEDDRA-PT E18 Dyskinesia
A79	MEDDRA-PT-ID E18 10013916
A80	LLT E18 Movements involuntary
A81	LLT-ID E18 10028041
A82	CUI E19 C0234428
A83	UMLS-Preferred-Name E19 Disturbance of consciousness
A84	MEDDRA-PT E19 Altered state of consciousness
A85	MEDDRA-PT-ID E19 10001854
A86	LLT E19 Consciousness abnormal
A87	LLT-ID E19 10010765
A88	CUI E20 C0856054
A89	UMLS-Preferred-Name E20 Mental status changes
A90	MEDDRA-PT E20 Mental status changes
A91	MEDDRA-PT-ID E20 10048294
A92	CUI E22 C0151744
A93	UMLS-Preferred-Name E22 Myocardial Ischemia
A94	MEDDRA-PT E22 Myocardial ischaemia
A95	MEDDRA-PT-ID E22 10028600
A96	LLT E22 Ischaemic heart disease
A97	LLT-ID E22 10023024
A98	CUI E23 C0003811
A99	UMLS-Preferred-Name E23 Cardiac Arrhythmia
A100	MEDDRA-PT E23 Arrhythmia
A101	MEDDRA-PT-ID E23 10003119
A102	CUI E24 C3532952
A103	UMLS-Preferred-Name E24 Exacerbation of congestive heart failure
A104	MEDDRA-PT E24 Cardiac failure congestive
A105	MEDDRA-PT-ID E24 10007559
A106	LLT E24 Congestive cardiac failure aggravated
A107	LLT-ID E24 10048565
A108	CUI E25 C0020517
A109	UMLS-Preferred-Name E25 Hypersensitivity
A110	MEDDRA-PT E25 Hypersensitivity
A111	MEDDRA-PT-ID E25 10020751
A112	LLT E25 Allergic reaction
A113	LLT-ID E25 10001718
A114	CUI E27 C0004096
A115	UMLS-Preferred-Name E27 Asthma
A116	MEDDRA-PT E27 Asthma
A117	MEDDRA-PT-ID E27 10003553
A118	LLT E27 Asthma bronchial
A119	LLT-ID E27 10003555
A120	CUI E30 C1527304
A121	UMLS-Preferred-Name E30 Allergic Reaction
A122	MEDDRA-PT E30 Hypersensitivity
A123	MEDDRA-PT-ID E30 10020751
A124	LLT E30 Allergic reaction
A125	LLT-ID E30 10001718
